| Drug Name | Sunitinib |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Safety communication
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Potential Risk of Interstitial Lung Disease Associated with the Use Sunitinib |
| safety communication |
|